Startup · $26m raised
Sydney, NSW
Every investor coverage indicates participated in a round SpeeDx raised.
| Investor | Rounds | Invested |
|---|---|---|
| Northpond Ventures | Unnamed stage | - |
| Platinum International Healthcare Fund | Unnamed stage | - |
| Tenmile | Unnamed stage | $5,000,000 |
Companies SpeeDx acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming SpeeDx. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
A weekly roundup reports four Australian companies together securing about $60 million: Unyoked, SpeeDx, Mutinex and Live Verdure, with funds earmarked for European and US expansion and product development.
Sydney diagnostics developer SpeeDx banked $26 million for American expansion, with $5 million from Andrew Forrest's new fund Tenmile and follow-on support from Platinum and Northpond.
Also SmartCompany
Roundup covering Instacart's US$265 million raise, Xendit's Series B, EZZ Life Science's ASX debut, Grimes' NFT art sales, Service NSW app usage figures, and a Cicada Innovations women-in-STEM event.
A Startup Daily series marking Cicada Innovations' 20th anniversary profiles SpeeDx, a biotech founded by Alison Todd and Elisa Mokany, whose enzyme-based diagnostics help clinicians treat superbugs and infectious diseases.
Weekly roundup reporting seven startup raises, led by Fluent Commerce's Series B backed by Arrowroot Capital, plus funding for SpeeDx, eftsure, handdii, Pharmamark Nutrition, DC Power Co and Lumary.